Patents by Inventor Barry Slobedman

Barry Slobedman has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • CMV IMMUNO-STIMULATORY COMPOSITION
    Publication number: 20160243216
    Abstract: The invention relates to a CMV strain comprising interferon bets (IFNb) useful in immuno-stimulatory compositions and vaccines
    Type: Application
    Filed: October 28, 2014
    Publication date: August 25, 2016
    Inventors: Barry Slobedman, Simone Forbes
  • Latent phase viral interleukin-10-(VII-10) and uses thereof
    Patent number: 8133700
    Abstract: The present invention relates to a purified nucleic acid sequence encoding a homologue of human interleukin 10 (IL-10), wherein said IL-10 homologue is expressed during the latent phase of infection by a virus of the herpesvirideae group. The present invention also relates to uses of this polypeptide, in particular for diagnosing disease states and screening for modulator and inhibitor compounds of such polypeptides and in turn the virus itself, screening for infection in vertebrates and biological tissue, cleansing of infected biological tissues, and in the treatment and/or prophylaxis and/or diagnosis of disease caused by a virus of the herpesvirideae group.
    Type: Grant
    Filed: November 26, 2004
    Date of Patent: March 13, 2012
    Assignee: The University of Sydney
    Inventors: Barry Slobedman, Allison Denise Abendroth, Christina Anne Jenkins
  • Latent phase viral interleukin-10-(VII-10) and uses thereof
    Publication number: 20090214463
    Abstract: The present invention relates to a purified nucleic acid sequence encoding a homologue of human interleukin 10 (IL-10), wherein said IL-10 homologue is expressed during the latent phase of infection by a virus of the herpesvirideae group. The present invention also relates to uses of this polypeptide, in particular for diagnosing disease states and screening for modulator and inhibitor compounds of such polypeptides and in turn the virus itself, screening for infection in vertebrates and biological tissue, cleansing of infected biological tissues, and in the treatment and/or prophylaxis and/or diagnosis of disease caused by a virus of the herpesvirideae group.
    Type: Application
    Filed: November 26, 2004
    Publication date: August 27, 2009
    Inventors: Barry Slobedman, Allison Denise Abendroth, Christina Anne Jenkins